Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
BMS's Abecma Faces J&J Threat Despite Pivotal Success In Earlier Myeloma Setting
Both Rivals Tout Blockbuster Potential
13 Feb 2023
•
By
Ayisha Sharma
More Than 35,000 New Cases Of Multiple Myeloma Are Expected In 2023 • Source: Shutterstock
More from Clinical Trials
More from R&D